VYGR

VOYAGER THERAPEUTICS INC

VYGR·92915B106·US·Common Stock·Healthcare - Biotechnology-13D/G

VYGR (VOYAGER THERAPEUTICS INC) is held by 81 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($21.5M), MILLENNIUM MANAGEMENT LLC ($13.2M), VANGUARD CAPITAL MANAGEMENT LLC ($8.8M). Net institutional sentiment: Mixed.

81
Holders
Avg rating(21 Elite)
$88.5M
Total Value
56% (92)
Fund Consensus
45 buying - 36 selling
VYGRSmart Money Verdict
View all
Held by 81 funds
21 elite
Who's Trading
ActivistECEcoR1 Capital, LLC0.0%May 15, 2026
ActivistARArmistice Capital, LLC5.9%May 15, 2026
InsiderSASandrock AlfredSell $45KApr 2, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
InsiderSASandrock AlfredSell $54KFeb 24, 2026
InsiderSRSwartz RobinSell $24KFeb 24, 2026
InsiderJDJorgensen Nathan D.Sell $18KFeb 24, 2026
InsiderCACarter Todd AlfredSell $16KFeb 24, 2026
InsiderSASandrock AlfredSell $40KFeb 18, 2026
InsiderSRSwartz RobinSell $13KFeb 18, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
5.6M(-0.9%)$21.5M0.0%-36.55%
0
Increased
3.4M(+82.3%)$13.2M0.0%-16.30%
43
New
2.3M$8.8M0.0%-15.48%
38
Decreased
1.1M(-8.4%)$4.2M0.0%-52.30%
0
Decreased
1M(-7.5%)$4.1M0.0%-63.27%
0
Increased
948,226(+1.3%)$3.7M0.0%-60.35%
27
Decreased
875,568(-19.3%)$3.4M0.0%-51.10%
0
New
725,769$2.8M0.0%-15.48%
36
Increased
681,711(+25.3%)$2.6M0.0%-39.55%
32
Increased
615,660(+176.4%)$2.4M0.0%-18.08%
42
Increased
578,024(+95.0%)$2.2M0.0%-15.19%
41
Increased
427,597(+41.1%)$1.7M0.0%-27.39%
34
Increased
384,843(+4.4%)$1.5M0.0%-68.63%
27
Decreased
364,664(-34.5%)$1.4M0.0%-13.73%
0
New
298,322$1.2M0.0%-15.48%
35
Decreased
276,867(-15.1%)$1.1M0.0%-31.74%
0
Increased
268,223(+181.3%)$1M0.0%-14.51%
40
Increased
232,681(+45.4%)$898,1490.0%-30.64%
34
New
193,984$748,7780.0%-15.48%
34
Increased
163,682(+15.5%)$631,8140.0%-29.08%
19

Showing 1-20 of 92

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used